Incyte | INCY - 税前利润



金融业
股票价格
USD
资产
USD 7.87B
现金及等价物
USD 3.98B
销售成本
USD 104.96M
流动资产
USD 6.03B
流动负债
USD 1.31B
债务
USD 38.27M
EBIT
USD 700.4M
EBITDA
USD 778.57M
员工
2.62K
EPS每股收益
USD 3.09
股本和储备
USD 6.34B
销售毛利
USD 1.57B
债务利息支出
USD 582K
利息收入
USD 38.12M
贷款资金
USD 28.42M
市值
USD 27.1B
净收入
USD 585.61M
营业费用
USD 973.64M
营业利润
USD 700.4M
普通股股本
USD 200.98M
PE价格收益
14.45
税前利润
USD 751.51M
销售收入
USD 1.67B
销售和管理费用
USD 351.74M
股票
USD 112.54M
贸易债权人
USD 1.39B
应收帐款人
USD 1.13B


税前利润 更改 日
Acadia Pharmaceuticals USD 46.47M 42.49M 2026-06
Agenus USD 39.21M 49.82M 2026-03
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Alnylam Pharmaceuticals USD 177.81M 43.85M 2026-06
Amgen USD 2.08B 570M 2026-03
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
Biogen USD 647.3M 269.6M 2026-06
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Eli Lilly USD 8.85B 583.8M 2026-03
Exelixis USD 262.68M 5.01M 2026-06
Gilead Sciences USD -7.53B 10.11B 2026-06
Incyte USD 751.51M 407.91M 2026-06
Ionis Pharmaceuticals USD -114M 21M 2026-06
MacroGenics USD -36.77M 21.84M 2026-03
Merck USD -3.53B 6.95B 2026-03
Moderna USD -1.33B 535M 2026-03
Nektar Therapeutics USD -43.09M 8.39M 2026-03
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
Novartis USD 4.27B 430M 2026-06
Novartis USD 3.84B 1.33B 2026-03
Pfizer USD -653M 5.84B 2026-06
PTC Therapeutics USD -2.46M 136.62M 2026-03
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Sarepta Therapeutics USD -1.75M 344.92M 2026-06
Ultragenyx Pharmaceutical USD -91M 93M 2026-06
Vertex Pharmaceuticals USD 1.39B 138.9M 2026-06